Multi award-winning, ISO-accredited language services agency My Language Connection (MLC) will showcase how AI-enabled translation can accelerate global MedTech and Pharma product launches at WHX Dubai. The company is credited by the likes of DexCom, Inc. and Norm by FIRE1 for helping bring their first human patients into clinical trials faster through its copywritten localisation process workflows, now known as ORBIT-L.
MedTech and pharmaceutical organisations looking to accelerate international product launches are invited to a dedicated presentation at WHX Dubai, where industry experts will explore how AI-enabled translation can significantly reduce time-to-market without compromising quality or compliance.
The session, Accelerating Product Launches with AI-Enabled Translation, will take place on Monday 9 February, from 12.30–1.00pm (GMT+4) at Expo City Dubai, hosted at the UK Pavilion, ABHI Main Stand (S7.E50).
Delivered by Victoria Nicol, Founder and CEO of My Language Connection (MLC), the presentation will address one of the biggest challenges facing regulated organisations today: managing complex multilingual localisation across global markets while maintaining regulatory control.
As MedTech and pharma companies scale internationally, they often face fragmented translation workflows involving multiple vendors, systems, and stakeholders. This complexity can create heavy administrative burden, slow product launches, and increase operational risk. During the session, attendees will gain practical insight into how localisation can be simplified through a single, structured workflow that centralises technology, quality assurance, and delivery.
Victoria Nicol will introduce ORBIT-L, MLC’s proprietary AI-enabled localisation platform designed specifically for regulated industries. ORBIT-L combines intelligent automation with expert human linguists, enabling organisations to streamline end-to-end translation workflows while keeping regulatory and linguistic expertise firmly at the core.
A live demonstration will show how ORBIT-L supports everything from content intake and automation through to quality control and final delivery—helping teams reduce manual effort, improve visibility, and bring products to market faster with confidence. The platform integrates seamlessly with existing systems and supports bespoke workflows tailored to organisational needs.
As an ISO-accredited Language Service Integrator, MLC works with a global network of over 875 specialist medical and pharmaceutical linguists, covering 250+ languages, and brings more than 35 years of combined industry experience across its team. The company is recognised for helping regulated organisations navigate global markets efficiently while maintaining the highest quality standards.
Those unable to attend the session are encouraged to visit MLC at Stand S7.F90, Pod O within the UK Pavilion, or to book a one-to-one meeting in advance to discuss specific localisation challenges and upcoming projects.
This session is set to be a must-attend for MedTech and pharmaceutical leaders seeking smarter, faster, and more controlled routes to global market entry.
For more information or to register here: https://www.eventbrite.com/e/accelerating-product-launches-with-ai-enabled-translation-tickets-1981…
